Article Details

Chinese biopharma startup secures Series B funding for innovative biologics

Retrieved on: 2021-02-19 05:03:45

Tags for this article:

Click the tags to see associated articles and topics

Chinese biopharma startup secures Series B funding for innovative biologics. View article details on hiswai:

Excerpt

Hangzhou Sciwind Biosciences Co., Ltd. (Sciwind), a clinical-stage fast-growing biopharmaceutical company focusing on research and development ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo